Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$12.24 - $21.25 $5.87 Million - $10.2 Million
-479,651 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$16.69 - $26.05 $77,491 - $120,950
4,643 Added 0.98%
479,651 $9.23 Million
Q2 2021

Aug 16, 2021

SELL
$18.15 - $27.75 $1.33 Million - $2.03 Million
-73,044 Reduced 13.33%
475,008 $12 Million
Q1 2021

May 12, 2021

BUY
$20.71 - $51.02 $3.28 Million - $8.08 Million
158,281 Added 40.61%
548,052 $13.5 Million
Q4 2020

Feb 16, 2021

SELL
$21.84 - $44.0 $3.09 Million - $6.23 Million
-141,500 Reduced 26.63%
389,771 $14.3 Million
Q3 2020

Nov 16, 2020

BUY
$13.63 - $24.12 $6.05 Million - $10.7 Million
444,060 Added 509.18%
531,271 $11.5 Million
Q2 2020

Aug 14, 2020

BUY
$7.65 - $14.11 $667,164 - $1.23 Million
87,211 New
87,211 $1.13 Million
Q3 2019

Nov 14, 2019

SELL
$14.16 - $25.34 $920,400 - $1.65 Million
-65,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$27.0 - $30.25 $1.76 Million - $1.97 Million
65,000 New
65,000 $1.77 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $225M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.